Steven Lee Yatomi-Clarke, Managing Director & Chief Executive Officer at Prescient Therapeutics Limited, holds 11.20M shares in Prescient Therapeutics Limited (Ticker: AU:PTX).
What is the percentage of profitable transactions made by Steven Lee Yatomi-Clarke?
The percentage of profitable transactions made by Steven Lee Yatomi-Clarke is 40%.
What is the average return per transaction made by Steven Lee Yatomi-Clarke?
The average return per transaction made by Steven Lee Yatomi-Clarke is 24.20%.
What stocks does Steven Lee Yatomi-Clarke hold?
Steven Lee Yatomi-Clarke holds: AU:PTX stocks.
What was Steven Lee Yatomi-Clarke’s latest transaction?
Steven Lee Yatomi-Clarke latest transaction was an Uninformative Sell of ―.
What was Steven Lee Yatomi-Clarke's most profitable transaction?
Steven Lee Yatomi-Clarke’s most profitable transaction was an Informative Buy of AU:PTX stock on August 31, 2020. The return on the trade was 167.10%.
What is Steven Lee Yatomi-Clarke's role in Prescient Therapeutics Limited?
Steven Lee Yatomi-Clarke's role in Prescient Therapeutics Limited is Managing Director & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.